Updates are available Correction dated 2022-05-07

Article History

Received: 14 May 2020

Accepted: 30 August 2020

First Online: 26 September 2020

Change Date: 7 May 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00345-022-04032-0

Compliance with ethical standards

:

: PD has recently received speaker fees from Bayer, Boehringer Ingelheim and Ferring Pharmaceuticals. In the past 36 months, MK has received funding for lecturing and conference attendance from Besins Healthcare, Astra Zeneca, Eli Lilly, Boehringer Ingelheim, Pfizer and Prostate Cancer UK.

: The Optimum Patient Care Research Database (OPCRD) used for the analysis of new UK real-world data in this article is approved by Trent Multi Centre Research Ethics Committee for clinical research use.